Nachrichten zur Repligen Corp. Aktie

Repligen: Prognose-Upgrade und BioLife-Deal befeuern Biopharma-Aktie

Starke Quartalszahlen: Repligen übertrifft Marktschätzungen bei Umsatz und Gewinn deutlich und verzeichnet einen rasanten Auftragseingang. Prognose-Upgrade & Zukauf: Der…

Repligen to buy cell therapy maker BioLife in $1.5 billion deal

Repligen Corp said on Wednesday it would buy ?BioLife Solutions in a cash-and-stock deal valued at about $1.5 billion, to…

Biolife Is Said to Have Drawn Takeover Interest From Repligen

Biolife Solutions Inc. has attracted takeover interest from parties including diagnostics company Repligen Corp., according to people with knowledge of…

908 Devices (MASS) Q4 2025 Earnings Transcript

Image source: The Motley Fool.DateTuesday, March 3, 2026 at 8:30 a.m. ETCall participantsChief Executive Officer and Co-Founder — Kevin J.…

Repligens Q4 Earnings Beat Estimates, Revenues Surge Y/Y

RGEN tops Q4 EPS estimates as revenues jump 18% Y/Y, with solid organic growth and stronger margins heading into 2026.…

Repligens Q4 Earnings Beat Estimates, Revenues In Line

RGEN reports decent fourth-quarter results and issues guidance for 2025.…

Repligens Q4 Slightly Tops Expectations

The bioprocessing technology specialists fourth-quarter results were dragged down by restructuring costs.…

After-hours movers: Steelcase, Hess Midstream Partners, Repligen By Investing.com

After-hours movers: Steelcase, Hess Midstream Partners, Repligen…

Maravai Lifesciences Shares Soar After Reported Takeover Offer

Maravai Lifesciences Holdings Inc. shares soared after a report that the company received a takeover offer from Repligen Corp.…

Repligens (RGEN) Q2 Earnings & Revenues Meet Estimates

Repligens (RGEN) second-quarter earnings and revenues match estimates. The company narrows its revenue guidance for 2024. Stock rises.…

dpa-AFX ProFeed